Rocket Pharmaceuticals Inc.
RCKT | NASDAQ
$3.35
+$0.08 (+2.45%)
Sep 22, 2026, 1:46 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 123.21M | -47.59M | -42.54M | -50.33M | -68.92M | -61.33M | -60.33M | -66.72M | -69.65M | -62.05M | -59.66M | -61.9M | -65.7M | -58.34M | -66.72M | -57.76M | -54.4M | -42.98M | -44.25M | -50.12M | -34.53M | -40.18M |
Depreciation & Amortization | 2.1M | 2.15M | 2.22M | 3.24M | 2.58M | 2.99M | 2.36M | 2.42M | 2.37M | 2.25M | 2.37M | 1.76M | 1.73M | 1.67M | 1.78M | 1.09M | 496K | 1.3M | 3.19M | 800K | 700K | 674K |
Stock-Based Compensation | 7.42M | 8.49M | 6.11M | 9.76M | 10.86M | 10.33M | 11.09M | 11.25M | 11.33M | 10.25M | n/a | 10.32M | 10.25M | 8.92M | n/a | 7.68M | 7.37M | 6.27M | 7.04M | n/a | n/a | 7.9M |
Other Working Capital | 735K | -7.42M | 195K | -11.5M | 8.73M | -5.71M | -732K | 248K | 4.33M | -4.58M | 21.5M | -5.94M | 5.34M | -7.51M | 132K | 4.45M | 3.34M | -4.48M | -3.18M | 6.08M | -14.11M | 6.18M |
Other Non-Cash Items | -178.83M | -1.02M | -826K | -1.6M | -2.21M | -2.08M | 653K | 699K | -2.24M | -2.75M | 6.43M | -13.85M | -2.49M | -2.34M | 8.75M | 690K | 1.61M | 617K | 6.26M | 15.37M | 8.16M | 1.21M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 12.47M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 6.48M | -7.42M | 195K | -11.5M | 8.73M | -5.71M | -732K | 248K | 4.33M | -4.58M | 21.5M | -5.94M | 5.34M | -7.51M | 132K | 4.45M | 5.89M | -4.48M | -3.18M | 6.08M | -14.11M | 6.18M |
Operating Cash Flow | -39.61M | -45.39M | -34.84M | -50.43M | -48.96M | -55.8M | -46.96M | -52.1M | -53.85M | -56.88M | -29.37M | -57.15M | -50.87M | -57.6M | -56.06M | -43.86M | -39.04M | -39.27M | -30.94M | -27.87M | -39.77M | -24.22M |
Capital Expenditures | -8K | -93K | -80K | 54K | -50K | -364K | -309K | -1.59M | -1.93M | -2.04M | -4.65M | -4.66M | -4.15M | -3.02M | -3.26M | -503K | -2.9M | -1.96M | -2.04M | -3.84M | -1.51M | -328K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -52.91K | -35.33K | n/a | 42.73M | -23.97K | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -14.82M | -48.71M | -54.5M | -29.44M | -52.69M | -139.93M | -124.05M | -19.32M | -38.57M | -63.95M | -208.5M | -13.49M | -72.9M | -96.03M | -198.87M | -34.44M | -143.02M | -143.02M | -19.39M | -67.91M | -54.76M | -103.82M |
Sales Maturities Of Investments | 51M | 66.25M | 91M | 123M | 84.5M | 82.26M | 86.48M | 99.83M | 96.13M | 101.02M | 72.34M | 66.4M | 108.25M | 62.34M | 50.82M | 58.41M | 81.69M | 81.98M | 38.3M | 53.56M | 105.62M | 74.97M |
Other Investing Acitivies | 178.19M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 52.91K | 35.33K | n/a | n/a | 23.97K | 143.02M | n/a | 748K | n/a | n/a | n/a |
Investing Cash Flow | 214.36M | 17.45M | 36.43M | 93.62M | 31.76M | -58.04M | -37.87M | 78.92M | 55.62M | 35.03M | -140.81M | 48.25M | 31.21M | -36.72M | -108.59M | 23.47M | 78.79M | -63M | 16.86M | -18.19M | 49.35M | -29.17M |
Debt Repayment | n/a | -1K | n/a | 8K | 13K | 12K | 15K | 24K | 29K | 27K | 30K | 35K | n/a | 37K | 38K | n/a | n/a | 45K | n/a | 460K | 1.25M | -63K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -47K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -2K | n/a | n/a | -67K | -13K | n/a | n/a | -24K | n/a | n/a | n/a | -35K | n/a | n/a | n/a | n/a | n/a | n/a | 11.33M | n/a | n/a | n/a |
Financial Cash Flow | 150K | -1K | n/a | -59K | 215K | 12K | 182.86M | 176K | 1.56M | 1.21M | 421K | 189.49M | 182K | 18.38M | 108.48M | 29.53M | 17.25M | 121K | 1.14M | 27.1M | 2.36M | 8.73M |
Net Cash Flow | 174.9M | -27.95M | 1.59M | 43.13M | -16.99M | -113.83M | 98.04M | 26.99M | 3.33M | -20.63M | -169.75M | 180.59M | -19.48M | -75.94M | -56.15M | 9.13M | 57M | -102.14M | -12.94M | -18.96M | 12.07M | -44.56M |
Free Cash Flow | -39.62M | -45.49M | -34.92M | -50.37M | -49.01M | -56.17M | -47.27M | -53.69M | -55.78M | -58.92M | -34.02M | -61.8M | -55.02M | -60.62M | -59.32M | -44.36M | -41.94M | -41.22M | -32.98M | -31.71M | -41.28M | -24.55M |
Adj. Free Cash Flow | -47.04M | -53.98M | -41.03M | -60.13M | -59.87M | -66.5M | -58.35M | -64.94M | -67.11M | -69.17M | -34.02M | -72.12M | -65.26M | -69.53M | -59.32M | -52.04M | -49.31M | -47.49M | -40.02M | -31.71M | -41.28M | -32.45M |
Maintenance CapEx | -8K | -93K | -80K | -54K | -50K | -364K | -309K | -1.59M | -1.93M | -2.04M | -2.37M | -1.76M | -1.73M | -1.67M | -1.78M | -503K | -496K | -1.3M | -2.04M | -800K | -700K | -328K |
Growth CapEx | n/a | n/a | n/a | 108K | n/a | n/a | n/a | n/a | n/a | n/a | -2.28M | -2.9M | -2.42M | -1.35M | -1.49M | n/a | -2.4M | -653K | n/a | -3.04M | -807K | n/a |
Owner Earnings | -39.62M | -45.49M | -34.92M | -50.48M | -49.01M | -56.17M | -47.27M | -53.69M | -55.78M | -58.92M | -31.74M | -58.91M | -52.6M | -59.27M | -57.84M | -44.36M | -39.54M | -40.57M | -32.98M | -28.67M | -40.47M | -24.55M |
Add to Watchlist
Select watchlists to add or remove RCKT